Ellagic Acid Prevents Particulate Matter-Induced Pulmonary Inflammation and Hyperactivity in Mice: A Pilot Study

Area of Science:

• Environmental Health
• Toxicology
• Neuroscience

Background:

• Fine particulate matter (PM) inhalation is a major environmental health concern.
• Previous studies linked PM exposure to lung inflammation, hypoxia, and behavioral changes like hyperactivity in mice.
• Ellagic acid (EA) is a natural polyphenol with potential therapeutic properties.

Purpose of the Study:

• To investigate the efficacy of ellagic acid (EA) in preventing pulmonary and behavioral abnormalities induced by particulate matter (PM) exposure.
• To evaluate the impact of EA on inflammatory and hypoxic responses in the lungs following PM exposure.
• To assess the effect of EA on PM-induced hyperactivity in mice.

Main Methods:

• Mice were divided into four groups: control, PM-instilled (PMI), low-dose EA + PMI, and high-dose EA + PMI.
• EA was administered orally for 14 days, with PM instilled intratracheally for the final 7 days.
• Lung inflammation, inflammatory/hypoxic gene expression, and open field test behavior were analyzed.

Main Results:

• PM exposure led to lung inflammation, increased inflammatory proteins, and elevated expression of inflammatory (Tnfα, Il-1b, Il-6) and hypoxic (Vegfα, Ankrd37) genes.
• EA pretreatment significantly inhibited the induction of these inflammatory and hypoxic genes in the lungs.
• PM exposure caused hyperactivity, which was markedly prevented by EA pretreatment.

Conclusions:

• Dietary intervention with ellagic acid (EA) demonstrates potential in preventing particulate matter (PM)-induced lung pathology.
• EA pretreatment effectively mitigates PM-induced inflammatory and hypoxic responses in the lungs.
• Ellagic acid may serve as a protective strategy against PM-induced behavioral alterations and associated health risks.